06/20/2024
3:31 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:33 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:28 PM | Allogene Therapeutics (Issuer)
Kazam Joshua A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:29 PM | Allogene Therapeutics (Issuer)
WITTE OWEN N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:30 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:33 PM | Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/07/2024
4:34 PM | Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:35 PM | Allogene Therapeutics (Issuer)
Mayo Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:25 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
1:08 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
8:33 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:01 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:02 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:38 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
05/14/2024
3:40 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:02 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
11:15 PM | Allogene Therapeutics (Filer)
| Form EFFECT | |
04/24/2024
3:18 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:31 PM | Allogene Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:32 PM | Allogene Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:33 PM | Allogene Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:09 PM | Allogene Therapeutics (Subject)
MOORE TIMOTHY L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
7:10 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:28 PM | Allogene Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024
4:21 PM | Allogene Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2024
3:51 PM | Allogene Therapeutics (Filer)
| Form POSASR | |
03/14/2024
3:55 PM | Allogene Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
3:31 PM | Allogene Therapeutics (Subject)
Chang David D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
8:52 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:30 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Allogene Therapeutics (Subject)
Belldegrun Arie (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
4:45 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:46 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:47 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:48 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:51 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:42 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | Allogene Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. |
01/24/2024
4:25 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
9:02 AM | Allogene Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:11 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:00 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:26 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:46 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:17 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:41 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
10/25/2023
4:29 PM | Allogene Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13D/A | |
10/17/2023
3:34 PM | Allogene Therapeutics (Filer)
| Form 8-K/A | |
10/16/2023
6:25 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
7:31 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
